Suchergebnisse - (Person:"Zhang, Xiang")

PubPharm (77)

1

Immune-like sandwich multiple hotspots SERS biosensor for ultrasensitive detection of NDKA biomarker in serum

enthalten in: Talanta | 2024

von Zhang, X. | Gan, T. | Xu, Z. | +9

2

Soluble PD-L1 : a potential dynamic predictive biomarker for immunotherapy in patients with proficient mismatch repair colorectal cancer

enthalten in: Journal of translational medicine | 2023

von He, Y. | Zhang, X. | Zhu, M. | +10

3

Mutational and transcriptional alterations and clinicopathological factors predict the prognosis of stage I hepatocellular carcinoma : Prediction of stage I HCC prognosis

enthalten in: BMC gastroenterology | 2022

von Li, Z. | Gao, H. | Zhang, X. | +2

4

DICER1-associated sarcoma of the aortic arch - a case report and literature review

enthalten in: Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology | 2022

von Zheng, Y. | Ren, L. | Zhu, Y. | +9

5

Integrated multi-omics profiling of high-grade estrogen receptor-positive, HER2-negative breast cancer

enthalten in: Molecular oncology | 2022

von Wang, K. | Li, L. | Franch-Expósito, S. | +12

6

circCUL2 induces an inflammatory CAF phenotype in pancreatic ductal adenocarcinoma via the activation of the MyD88-dependent NF-κB signaling pathway

enthalten in: Journal of experimental & clinical cancer research : CR | 2022

von Zheng, S. | Hu, C. | Lin, H. | +7

7

Clinicopathological and molecular genomic features of monomorphic epitheliotropic intestinal T-cell lymphoma in the Chinese population : a study of 20 cases

enthalten in: Diagnostic pathology | 2021

von Chen, C. | Gong, Y. | Yang, Y. | +10

8

Prognostic impact of tumor length in esophageal Cancer : a systematic review and Meta-analysis

enthalten in: BMC cancer | 2021

von Wang, Z. | Jiang, Y. | Xiao, W. | +3

9

A seven-m6A regulator-related CpG site-based prognostic signature for endometrial carcinoma

enthalten in: Medicine | 2021

von Zhang, X. | Pang, X. | Huang, Y. | +1

10

MAP4K1 functions as a tumor promotor and drug mediator for AML via modulation of DNA damage/repair system and MAPK pathway

enthalten in: EBioMedicine | 2021

von Ling, Q. | Li, F. | Zhang, X. | +13

CommentIn: EBioMedicine. 2021 Aug;70:103488. - PMID 34280781

1
2
3
4
5
6
7
8
Nächster »
[8]